Literature DB >> 34035535

COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence.

Felipe Gomes Naveca1, Valdinete Nascimento2, Victor Costa de Souza2, André de Lima Corado2, Fernanda Nascimento2, George Silva2, Ágatha Costa2, Débora Duarte2, Karina Pessoa2, Matilde Mejía2, Maria Júlia Brandão2, Michele Jesus3, Luciana Gonçalves4, Cristiano Fernandes da Costa4, Vanderson Sampaio4, Daniel Barros4, Marineide Silva5, Tirza Mattos5, Gemilson Pontes6, Ligia Abdalla7, João Hugo Santos8, Ighor Arantes9, Filipe Zimmer Dezordi10, Marilda Mendonça Siqueira11, Gabriel Luz Wallau10, Paola Cristina Resende11, Edson Delatorre12, Tiago Gräf13, Gonzalo Bello14.   

Abstract

The northern state of Amazonas is among the regions in Brazil most heavily affected by the COVID-19 epidemic and has experienced two exponentially growing waves, in early and late 2020. Through a genomic epidemiology study based on 250 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from different Amazonas municipalities sampled between March 2020 and January 2021, we reveal that the first exponential growth phase was driven mostly by the dissemination of lineage B.1.195, which was gradually replaced by lineage B.1.1.28 between May and June 2020. The second wave coincides with the emergence of the variant of concern (VOC) P.1, which evolved from a local B.1.1.28 clade in late November 2020 and replaced the parental lineage in <2 months. Our findings support the conclusion that successive lineage replacements in Amazonas were driven by a complex combination of variable levels of social distancing measures and the emergence of a more transmissible VOC P.1 virus. These data provide insights to understanding the mechanisms underlying the COVID-19 epidemic waves and the risk of dissemination of SARS-CoV-2 VOC P.1 in Brazil and, potentially, worldwide.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34035535     DOI: 10.1038/s41591-021-01378-7

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  105 in total

1.  Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.

Authors:  Priscila Lamb Wink; Rafaela Ramalho; Francielle Liz Monteiro; Fabiana Caroline Zempulski Volpato; Julia Biz Willig; Otávio von Ameln Lovison; Alexandre Prehn Zavascki; Afonso Luís Barth; Andreza Francisco Martins
Journal:  Microbiol Spectr       Date:  2022-02-16

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

Review 3.  Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal:  ACS Infect Dis       Date:  2022-08-08       Impact factor: 5.578

4.  The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Authors:  Beny Spira
Journal:  Cureus       Date:  2022-07-01

5.  Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil.

Authors:  Camila Malta Romano; Cristina Mendes de Oliveira; Luciane Sussuchi da Silva; José Eduardo Levi
Journal:  Front Med (Lausanne)       Date:  2022-06-17

6.  Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program.

Authors:  Joice P Silva; Aline B de Lima; Luige B Alvim; Frederico S V Malta; Cristiane P T B Mendonça; Paula L C Fonseca; Filipe R R Moreira; Daniel C Queiroz; Jorge G G Ferreira; Alessandro C S Ferreira; Renan P Souza; Renato S Aguiar; Danielle A G Zauli
Journal:  Viruses       Date:  2022-04-20       Impact factor: 5.818

Review 7.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

8.  Unusual SARS-CoV-2 intrahost diversity reveals lineage superinfection.

Authors:  Filipe Zimmer Dezordi; Paola Cristina Resende; Felipe Gomes Naveca; Valdinete Alves do Nascimento; Victor Costa de Souza; Anna Carolina Dias Paixão; Luciana Appolinario; Renata Serrano Lopes; Ana Carolina da Fonseca Mendonça; Alice Sampaio Barreto da Rocha; Taina Moreira Martins Venas; Elisa Cavalcante Pereira; Marcelo Henrique Santos Paiva; Cassia Docena; Matheus Filgueira Bezerra; Laís Ceschini Machado; Richard Steiner Salvato; Tatiana Schäffer Gregianini; Leticia Garay Martins; Felicidade Mota Pereira; Darcita Buerger Rovaris; Sandra Bianchini Fernandes; Rodrigo Ribeiro-Rodrigues; Thais Oliveira Costa; Joaquim Cesar Sousa; Fabio Miyajima; Edson Delatorre; Tiago Gräf; Gonzalo Bello; Marilda Mendonça Siqueira; Gabriel Luz Wallau
Journal:  Microb Genom       Date:  2022-03

9.  Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil.

Authors:  Severino Jefferson Ribeiro da Silva; Lindomar Pena
Journal:  One Health       Date:  2021-06-29

10.  The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another.

Authors:  Laurent Blairon; Roberto Cupaiolo; Sébastien Piteüs; Ingrid Beukinga; Marie Tré-Hardy
Journal:  J Virol Methods       Date:  2021-07-29       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.